Quirante, Ginalyn .
HRN: 24-42-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
CEFUROXIME 1.5GM (VIAL)
05/24/2025
05/25/2025
IV
1.5g
Q8h X 3 Doses
S/p D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes